Peptoid CCK receptor antagonists: pharmacological evaluation of CCK A , CCK B and mixed CCK A/B receptor antagonists

By Singh L.   Field M.J.   Hill D.R.   Horwell D.C.   McKnight A.T.   Roberts E.   Tang K.W.   Woodruff G.N.  

European Journal of Pharmacology, Vol. 286, Iss. 2, 1995-11 ,pp. : 185-191

Elsevier

Access to resources Recommend Favorite

Enhancement of Morphine Actions in Morphine-Naive and Morphine-Tolerant Mice by LY 235959, a Competitive Antagonist of the NMDA Receptor

By Bhargava H.N.  

General Pharmacology, Vol. 28, Iss. 1, 1997-01 ,pp. : 61-64

Elsevier

Access to resources Recommend Favorite

In mononeuropathic rats, the enhancement of morphine antinociception by L-365,260, a selective CCK B receptor antagonist, depends on the dose of systemic morphine and stimulus characteristics

By Idanpaan-Heikkila J.J.   Perrot S.   Guilbaud G.   Kayser V.  

European Journal of Pharmacology, Vol. 325, Iss. 2, 1997-05 ,pp. : 155-164

Elsevier

Access to resources Recommend Favorite

Pharmacological profile of T-0632, a novel potent and selective CCK A receptor antagonist, in vivo

By Taniguchi H.   Yazaki N.   Yomota E.   Shikano T.   Endo T.   Nagasaki M.  

European Journal of Pharmacology, Vol. 312, Iss. 2, 1996-09 ,pp. : 227-233

Elsevier

Access to resources Recommend Favorite

His 381 of the rat CCK B receptor is essential for CCK B versus CCK A receptor antagonist selectivity

By Jagerschmidt A.   Guillaume-Rousselet N.   Vikland M.-L.   Goudreau N.   Maigret B.   Roques B.-P.  

European Journal of Pharmacology, Vol. 296, Iss. 1, 1996-01 ,pp. : 97-106

Elsevier

Access to resources Recommend Favorite